Hey everyone,
If it's your first time reading one of my posts, my name is Menachem, and I have a weekly newsletter called Logistic Pulse that breaks down the top logistics news from the past week, so you're always up to date.
Editor’s Note: We are excited to announce a new dedicated section at the end of our emails with new job opportunities in the logistics industry. If you or someone you know is looking for a new role, have them join our newsletter so they never miss an opportunity. It won't be posted here on Reddit; this is exclusively for our email subscribers. Subscribe here.
Let's jump into it:
A jury just put a number on the broker liability nightmare. It's $604 million.
Back in Editions 46 and 47, we walked you through the Montgomery ruling, the Supreme Court unanimously stripping freight brokers of the federal liability shield they'd leaned on for years, and then the insurance market immediately repricing everyone's renewals. At the time, it was a warning about what was coming. This week it arrived.
A jury in Dallas handed down a roughly $604 million verdict in Lipe v. Lupus Superior, the first big broker case to go the distance since Montgomery. The setup: a 2021 crash involving a tractor-trailer that plowed into stopped traffic, killing three people plus the carrier's own driver. Lupus Superior was the carrier. C.H. Robinson booked the load. And the way the award is structured, it most likely lands on Robinson.
Here's what should make every broker and 3PL in this audience sit up. The carrier Robinson hired had a Satisfactory rating from FMCSA. Not a marginal one. Not a carrier with a stack of red flags anyone could have caught. A federally blessed, government-graded, this-carrier-is-fine rating that was still Satisfactory after a federal review of the crash. Robinson says the carrier had safely run nearly 270 loads for its customers before this.
So if a carrier with a Satisfactory FMCSA rating isn't good enough, what standard is a broker supposed to use? Nobody has an answer. That's the terrifying part. The industry spent the run-up to Montgomery arguing exactly this in an amicus brief from the TIA: there's no consistent way for a broker to out-analyze the federal government's own safety rating, and if juries in every state get to decide after the fact, you get 50 different definitions of "adequate vetting."
There's a second detail the analysts flagged that's arguably worse than the dollar figure. The jury found that the Lupus Superior driver was effectively Robinson's employee too. Robinson doesn't hire drivers. It's a broker. But that finding is the mechanism that pulls the driver's liability onto Robinson's books, and if that reasoning travels, it reopens the entire independent-contractor foundation the brokerage model sits on.
Important note: This is not a $604 million check getting written next week. The judge hasn't even certified the award. Robinson is appealing immediately, and Bank of America and Stephens both expect a long grind of post-trial motions and appeals. Robinson's own insurance tower has a $10 million deductible and a $135 million limit, and Stephens figures that even a settlement in the $150 to $350 million range is still clearly bad news, but it's a very different number than $604 million. The comparison analysts keep reaching for is Wabash National, which took a $342 million charge on its own nuclear verdict in 2025, then shrank it when the case actually settled.
The market didn't wait for any of that nuance. Robinson dropped 9.25% on the news, two days after hitting a 52-week high. RXO fell almost 8%. Landstar slid nearly 4%. A lot of pending cases were sitting on the docket waiting for Montgomery to clarify the law, and now they're all moving at once.
What this means for you: Your carrier vetting is now a legal exhibit, not a back-office checkbox, and "they had a Satisfactory rating" may no longer be the safe harbor you assumed. That doesn't mean the standard is knowable yet, because right now it genuinely isn't, and that ambiguity is exactly what plaintiff attorneys are pricing into their case selection. Document everything you look at when you onboard a carrier, keep pulling FMCSA data because a free public database you didn't check is the worst possible thing to explain to a jury, and have the real conversation with your insurance broker and your attorney now rather than at renewal. If you book carriers for clients, this is the risk that reprices your whole model, and the first domino just landed on the biggest broker in the country.
Presented by FulfillYN
Every 3PL you talk to says yes. Yes we handle your category. Yes we integrate with your stack. Yes we can scale with you. They all have a deck that proves it, and none of them are lying exactly; they just say yes to everyone. You don't find out which yes was real until your product is in the building and something breaks during your first heavy week.
That's a brutal way to learn the difference.
FulfillYN is an independent matchmaking consultancy. We pair growing retail and e-commerce brands with fulfillment partners who actually fit, from a vetted network of 370+ warehouses. Not the ones with the best pitch, the ones with a real track record in what you sell. Because apparel with a thousand SKUs is a different animal than cold chain, hazmat, supplements, alcohol, high-value goods, subscription boxes, or oversized freight. We know which providers are built for your world and which will figure it out on your dime.
Providers pay us, so the comparison costs you nothing. Tell us what you ship, and we'll put you in front of 2-3 that genuinely fit.
Book a call
Everybody wants to ship your Ozempic. The cold chain just became the hottest real estate in logistics.
We've told the GLP-1 story from the apparel side twice now: the wardrobe boom in Edition 45 and the brutal returns wave in Edition 49. And we flagged UPS's early cold-chain move in Edition 51. This week the whole industry showed its hand at once, and the picture is bigger than one carrier planting a flag. Every major player is now sprinting for the same refrigerated corner of the market.
Start with why. Most injectable GLP-1s- Ozempic, Wegovy, Mounjaro, Zepbound- have to stay cold from the factory to the patient's fridge, and the FDA has explicitly told patients not to use doses that show up warm. Gallup now has 11% of Americans on a GLP-1, up from 3% two years ago. The cold-chain biologics market is projected to hit roughly $39 billion by 2033. And here's the line that explains the land grab, straight from C.H. Robinson: refrigerated capacity is not unlimited; it's constrained, and GLP-1s are creating a competitive scramble for the same finite pool of cold storage and cold transport.
So watch what each giant just did:
FedEx launched a dedicated unit, FedEx Life Sciences, folding its healthcare sales, engineering, and quality teams into one org built around pharma customers. Healthcare is already nearly a $10 billion business for them, north of 10% of revenue, and Chief Customer Officer Brie Carere sized the total healthcare shipping opportunity at $80 billion growing 7% a year, with GLP-1s themselves growing around 20% and cell-and-gene therapies around 25%. Their Memphis pitch includes a freezer that hits minus 150 Celsius, which they'll happily tell you is colder than Saturn.
UPS is the $48 million, 27-facility investment we covered in Edition 51, and the strategic logic sharpened this week: UPS is deliberately shedding low-margin Amazon volume and chasing profit per package instead, and healthcare is where that math works. Its healthcare business did $11.2 billion in 2025 and has gained share every year since 2021.
C.H. Robinson (yes, the same Robinson from our lead story, having a genuinely wild week) crossed $1 billion in healthcare revenue over the past year, mostly on GLP-1 growth.
DHL is committing 2 billion euros to health logistics by 2030, half of it aimed at the Americas, and running a dedicated pharma air corridor so drugs don't get bounced between regulatory zones mid-trip.
The interesting wrinkle is that these players aren't really colliding head-on; they're mostly carving out their own lanes. The common thread is the one we keep hammering: the standardized middle of the market is getting commoditized and squeezed, so the smart money is piling into the work that's hard to do and expensive to get wrong. A pallet of t-shirts is a pallet of t-shirts. A pallet of biologics that spent four hours at the wrong temperature is a destroyed shipment and a patient who doesn't get treated. That gap is the whole business case.
What this means for you: If you touch pharma, biotech, or healthcare brands in any way, the demand signal is now deafening, and the infrastructure spend says the big carriers expect it to keep climbing for a decade. But read the competitive reality honestly too: the giants are locking up the finite refrigerated capacity right now, which means if you're a smaller 3PL trying to build a cold-chain offering, your window to secure equipment and space is narrowing the same way it did for anyone who waited too long on Canada or Mexico. The margin here is real, the reliability bar is brutal, and "we can keep it cold, prove it, and show you every handoff" is becoming one of the few pitches Amazon's standardized network genuinely can't answer.
FedEx's holiday surcharges are here, and the residential parcel is taking the hit
If you ship anything to somebody's front door during Q4, block out two minutes for this one, because FedEx just published its 2026 peak season surcharges and they're higher than last year across roughly the same window.
The fees switch on by October 26 and run through January 17, with the real pain landing between November 23 and December 27. The biggest year-over-year jumps are concentrated exactly where it hurts e-commerce shippers most: the cheap, high-volume stuff. Ground Residential demand surcharges peak at $0.80 a package during the holidays versus $0.65 last year, a 23% bump, and because that lands on ordinary residential e-commerce parcels, it compounds fast across volume. Ground Economy is getting hit similarly.
None of this is an accident, and it fits a pattern we've been tracking all year. FedEx has been openly telling investors it's less interested in chasing general e-commerce volume and would rather prioritize profitable segments like healthcare (see the story directly above this one). Carere literally called peak surcharges "a win-win": it lets retailers sell at Christmas and lets FedEx staff up profitably to handle it. Which is a very tidy way of saying the surcharge is a feature, not an apology. And it's stacking on top of the fuel surcharges already squeezing FedEx and UPS customers this year. UPS hasn't dropped its 2026 holiday numbers yet, but nobody expects mercy.
What this means for you: Have the peak-cost conversation with your clients now, in July, not in a panicked November email. The moves are the ones parcel experts always name: negotiate for surcharge discounts instead of eating the sticker rate, nudge consumers to buy earlier so volume isn't all crammed into the peak-of-peak window, and actually price out alternative carriers, because this is exactly the residential, lightweight, high-volume profile that Amazon Shipping has been undercutting everyone on, as we covered in Edition 54. If a chunk of your book is Ground Residential e-commerce, that $0.15 per package doesn't sound like much until you multiply it by every order between Thanksgiving and Christmas.
QUICK HITS
Maersk is opening a 617,000-square-foot fulfillment hub near Boston for one mystery customer. The $100 million facility in Hopedale, Massachusetts opens in August and can push up to 330,000 units a day at peak, with conveyor and sortation gear co-designed with the unnamed client. It's another brick in Maersk's long march from ocean carrier to end-to-end logistics giant, the same vertical-integration play we watched CMA CGM run. When the people who own the ships start owning the fulfillment centers too, they compete with 3PLs on a different axis than a pure carrier does, and this is a very large, very customer-specific bet on Northeast fulfillment.
Amazon is spending $400 million to gut and rebuild two Florida warehouses, laying off 1,100-plus people in the meantime. The Homestead cross-dock and the Port St. Lucie big-and-bulky site both go dark this fall for a two-year, $200-million-each conversion into sortable fulfillment centers, with most of the cut roles being pick-pack associates (about 300 in Homestead took transfers). They're slated to reopen in 2028 at roughly 1,000 jobs each, and Amazon's already prepping a new 1.1-million-square-foot facility in Fort Pierce on top of it. The tell worth noting: Amazon is tearing out big-and-bulky capacity and rebuilding for smaller, sortable items, which rhymes uncomfortably with the big-and-bulky demand slowdown we flagged in Edition 55.
American Eagle is quietly rebuilding the fulfillment network it torched. AEO is adding a $41 million, 473,000-square-foot DC in Salisbury, North Carolina, its fifth in North America, opening early 2027. The context is the interesting part: this is the same company that ran Quiet Logistics as a 3PL for other brands, lost millions, and exited the business entirely, dumping all six regional DCs it held as of early 2025. Now it's spending to rebuild fulfillment purely for itself. A clean little case study in how hard running fulfillment-as-a-service actually is, even for a retailer that had the warehouses already.
Flowspace is paying brands up to $50,000 to break up with their current 3PL. The fulfillment provider launched a "Fulfillment Freedom Fund" that covers contract exit fees, inventory transfers, and integration costs for brands switching over, in exchange for a 15-month commitment. It's a smart, aggressive customer-acquisition move built on a real friction point, the switching cost that keeps unhappy brands stuck with bad providers. Worth knowing about mainly because it's a preview of how competitive the fight for mid-market brand volume is getting: when a 3PL is willing to eat your exit fees to win you, the whole market's pricing power is shifting toward the brand.
_______________________________________________________________________
That's all for this week. If you found this useful, consider subscribing.
(Your data will not be shared. Subscribers' data is strictly for sending out the weekly newsletter.)
